Lecluse Y - Search Results

1

Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts.

Geoerger B, Grill J, Opolon P, Morizet J, Aubert G, Lecluse Y, van Beusechem VW, Gerritsen WR, Kirn DH, Vassal G. Geoerger B, et al. Among authors: lecluse y. Br J Cancer. 2003 Aug 4;89(3):577-84. doi: 10.1038/sj.bjc.6601102. Br J Cancer. 2003. PMID: 12888833 Free PMC article.

2

Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma.

Geoerger B, van Beusechem VW, Opolon P, Morizet J, Laudani L, Lecluse Y, Barrois M, Idema S, Grill J, Gerritsen WR, Vassal G. Geoerger B, et al. Among authors: lecluse y. J Gene Med. 2005 May;7(5):584-94. doi: 10.1002/jgm.703. J Gene Med. 2005. PMID: 15651070

3

In situ sensory adaptation of tumor-infiltrating T lymphocytes to peptide-MHC levels elicits strong antitumor reactivity.

Dorothée G, Vergnon I, El Hage F, Le Maux Chansac B, Ferrand V, Lécluse Y, Opolon P, Chouaib S, Bismuth G, Mami-Chouaib F. Dorothée G, et al. Among authors: lecluse y. J Immunol. 2005 Jun 1;174(11):6888-97. doi: 10.4049/jimmunol.174.11.6888. J Immunol. 2005. PMID: 15905531

4

NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors.

Le Maux Chansac B, Moretta A, Vergnon I, Opolon P, Lécluse Y, Grunenwald D, Kubin M, Soria JC, Chouaib S, Mami-Chouaib F. Le Maux Chansac B, et al. Among authors: lecluse y. J Immunol. 2005 Nov 1;175(9):5790-8. doi: 10.4049/jimmunol.175.9.5790. J Immunol. 2005. PMID: 16237071

5

A novel dendritic cell subset involved in tumor immunosurveillance.

Taieb J, Chaput N, Ménard C, Apetoh L, Ullrich E, Bonmort M, Péquignot M, Casares N, Terme M, Flament C, Opolon P, Lecluse Y, Métivier D, Tomasello E, Vivier E, Ghiringhelli F, Martin F, Klatzmann D, Poynard T, Tursz T, Raposo G, Yagita H, Ryffel B, Kroemer G, Zitvogel L. Taieb J, et al. Among authors: lecluse y. Nat Med. 2006 Feb;12(2):214-9. doi: 10.1038/nm1356. Epub 2006 Jan 29. Nat Med. 2006. PMID: 16444265

6

Expression of erythropoietin and its receptor in neuroblastomas.

Sartelet H, Fabre M, Castaing M, Bosq J, Racu I, Lagonotte E, Scott V, Lecluse Y, Barette S, Michiels S, Vassal G. Sartelet H, et al. Among authors: lecluse y. Cancer. 2007 Sep 1;110(5):1096-106. doi: 10.1002/cncr.22879. Cancer. 2007. PMID: 17647284 Free article.

7

Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells.

Tao Y, Zhang P, Frascogna V, Lecluse Y, Auperin A, Bourhis J, Deutsch E. Tao Y, et al. Among authors: lecluse y. Br J Cancer. 2007 Dec 17;97(12):1664-72. doi: 10.1038/sj.bjc.6604083. Epub 2007 Nov 20. Br J Cancer. 2007. PMID: 18026198 Free PMC article.

8

EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts.

Geoerger B, Gaspar N, Opolon P, Morizet J, Devanz P, Lecluse Y, Valent A, Lacroix L, Grill J, Vassal G. Geoerger B, et al. Among authors: lecluse y. Int J Cancer. 2008 Jul 1;123(1):209-16. doi: 10.1002/ijc.23488. Int J Cancer. 2008. PMID: 18386816

9

Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia.

Laurent AP, Siret A, Ignacimouttou C, Panchal K, Diop M, Jenni S, Tsai YC, Roos-Weil D, Aid Z, Prade N, Lagarde S, Plassard D, Pierron G, Daudigeos E, Lecluse Y, Droin N, Bornhauser BC, Cheung LC, Crispino JD, Gaudry M, Bernard OA, Macintyre E, Barin Bonnigal C, Kotecha RS, Geoerger B, Ballerini P, Bourquin JP, Delabesse E, Mercher T, Malinge S. Laurent AP, et al. Among authors: lecluse y. Clin Cancer Res. 2020 Jul 1;26(13):3307-3318. doi: 10.1158/1078-0432.CCR-19-3519. Epub 2020 Mar 27. Clin Cancer Res. 2020. PMID: 32220889 Free PMC article.

10

CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling.

Gati A, Guerra N, Gaudin C, Da Rocha S, Escudier B, Lécluse Y, Bettaieb A, Chouaib S, Caignard A. Gati A, et al. Among authors: lecluse y. Cancer Res. 2003 Nov 1;63(21):7475-82. Cancer Res. 2003. PMID: 14612548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters